Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control

被引:26
作者
Gaborit, B. [1 ,2 ]
Frere, C. [2 ]
Cuisset, T. [2 ]
Alessi, M. -C. [2 ]
Dutour, A. [1 ,2 ]
机构
[1] CHU Nord, Dept Endocrinol Metab Dis & Nutr, Marseille, France
[2] CHU Timone, INSERM, U626, Fac Med,Lab Haematol, Marseille, France
关键词
CORONARY-ARTERY-DISEASE; ANTIPLATELET THERAPY; MELLITUS; ACTIVATION; ASPIRIN;
D O I
10.1111/j.1538-7836.2009.03599.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1939 / 1941
页数:3
相关论文
共 9 条
[1]   Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel [J].
Ang, Lawrence ;
Palakodeti, Vachaspathi ;
Khalid, Ahmer ;
Tsimikas, Sotirios ;
Idrees, Zaheib ;
Tran, Phillip ;
Clopton, Paul ;
Zafar, Nayab ;
Bromberg-Marin, Guilherme ;
Keramati, Shahin ;
Mahmud, Ehtisham .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (13) :1052-1059
[2]   Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease [J].
Angiolillo, DJ ;
Fernandez-Ortiz, A ;
Bernardo, E ;
Ramírez, C ;
Sabaté, M ;
Jimenez-Quevedo, P ;
Hernández, R ;
Moreno, R ;
Escaned, J ;
Alfonso, F ;
Bañuelos, C ;
Costa, MA ;
Bass, TA ;
Macaya, C .
DIABETES, 2006, 55 (03) :780-784
[3]   Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study [J].
Angiolillo, Dominick J. ;
Shoemaker, Steven B. ;
Desai, Bhaloo ;
Yuan, Hang ;
Charlton, Ronald K. ;
Bernardo, Esther ;
Zenni, Martin M. ;
Guzman, Luis A. ;
Bass, Theodore A. ;
Costa, Marco A. .
CIRCULATION, 2007, 115 (06) :708-716
[4]   Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment [J].
Angiolillo, Dominick J. ;
Bernardo, Esther ;
Ramirez, Celia ;
Costa, Marco A. ;
Sabate, Manel ;
Jimenez-Quevedo, Pilar ;
Hernandez, Rosana ;
Moreno, Raul ;
Escaned, Javier ;
Alfonso, Fernando ;
Banuelos, Camino ;
Bass, Theodore A. ;
Macaya, Carlos ;
Fernandez-Ortiz, Antonio .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (02) :298-304
[5]   High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome [J].
Cuisset, T ;
Frere, C ;
Quilici, J ;
Barbou, F ;
Morange, PE ;
Hovasse, T ;
Bonnet, JL ;
Alessi, MC .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (03) :542-549
[6]   Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin [J].
Evangelista, V. ;
De Berardisj, G. ;
Totani, L. ;
Avanzini, F. ;
Giorda, C. B. ;
Brero, L. ;
Levantesi, G. ;
Marelli, G. ;
Pliipillo, M. ;
Iacuitti, G. ;
Pozzoli, G. ;
Di Summa, P. ;
Nada, E. ;
De Simone, G. ;
DelL'Elba, G. ;
Amore, C. ;
Manarini, S. ;
Pecce, R. ;
Maione, A. ;
Tognoni, G. ;
Nicolucci, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (11) :2197-2203
[7]   Platelet activation in type 2 diabetes mellitus [J].
Ferroni, P ;
Basili, S ;
Falco, A ;
Davì, G .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (08) :1282-1291
[8]   Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation [J].
Geisler, Tobias ;
Anders, Nicole ;
Paterok, Maria ;
Langer, Harald ;
Stellos, Konstantinos ;
Lindemann, Stephan ;
Herdeg, Christian ;
May, Andreas E. ;
Gawaz, Meinrad .
DIABETES CARE, 2007, 30 (02) :372-374
[9]   Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions [J].
Lepäntalo, A ;
Virtanen, KS ;
Heikkilä, J ;
Wartiovaara, U ;
Lassila, R .
EUROPEAN HEART JOURNAL, 2004, 25 (06) :476-483